Copyright Reports & Markets. All rights reserved.

Global Quetiapine Fumarate Sustained Release Tablets Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Quetiapine Fumarate Sustained Release Tablets by Type
    • 1.3.1 Overview: Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Quetiapine Fumarate Sustained Release Tablets Consumption Value Market Share by Type in 2025
    • 1.3.3 50mg
    • 1.3.4 200mg
    • 1.3.5 300mg
    • 1.3.6 400mg
  • 1.4 Global Quetiapine Fumarate Sustained Release Tablets Market by Application
    • 1.4.1 Overview: Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Quetiapine Fumarate Sustained Release Tablets Market Size & Forecast
  • 1.6 Global Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast by Region
    • 1.6.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region, (2021-2032)
    • 1.6.3 North America Quetiapine Fumarate Sustained Release Tablets Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Quetiapine Fumarate Sustained Release Tablets Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size and Prospect (2021-2032)
    • 1.6.6 South America Quetiapine Fumarate Sustained Release Tablets Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Luye Pharma Limited
    • 2.1.1 Luye Pharma Limited Details
    • 2.1.2 Luye Pharma Limited Major Business
    • 2.1.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.1.4 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Luye Pharma Limited Recent Developments and Future Plans
  • 2.2 PHARMATHEN INVESTMENTS GROUP LIMITED
    • 2.2.1 PHARMATHEN INVESTMENTS GROUP LIMITED Details
    • 2.2.2 PHARMATHEN INVESTMENTS GROUP LIMITED Major Business
    • 2.2.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.2.4 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 PHARMATHEN INVESTMENTS GROUP LIMITED Recent Developments and Future Plans
  • 2.3 Seroquel
    • 2.3.1 Seroquel Details
    • 2.3.2 Seroquel Major Business
    • 2.3.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.3.4 Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Seroquel Recent Developments and Future Plans
  • 2.4 Teva Pharmaceutical Industries
    • 2.4.1 Teva Pharmaceutical Industries Details
    • 2.4.2 Teva Pharmaceutical Industries Major Business
    • 2.4.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.4.4 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
  • 2.5 Dr. Reddy's Laboratories
    • 2.5.1 Dr. Reddy's Laboratories Details
    • 2.5.2 Dr. Reddy's Laboratories Major Business
    • 2.5.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.5.4 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Dr. Reddy's Laboratories Recent Developments and Future Plans
  • 2.6 Sun Pharmaceutical Industries
    • 2.6.1 Sun Pharmaceutical Industries Details
    • 2.6.2 Sun Pharmaceutical Industries Major Business
    • 2.6.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.6.4 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
  • 2.7 Mylan N.V.
    • 2.7.1 Mylan N.V. Details
    • 2.7.2 Mylan N.V. Major Business
    • 2.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.7.4 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Mylan N.V. Recent Developments and Future Plans
  • 2.8 Torrent Pharmaceuticals
    • 2.8.1 Torrent Pharmaceuticals Details
    • 2.8.2 Torrent Pharmaceuticals Major Business
    • 2.8.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.8.4 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Torrent Pharmaceuticals Recent Developments and Future Plans
  • 2.9 Lupin Limited
    • 2.9.1 Lupin Limited Details
    • 2.9.2 Lupin Limited Major Business
    • 2.9.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.9.4 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Lupin Limited Recent Developments and Future Plans
  • 2.10 Sandoz
    • 2.10.1 Sandoz Details
    • 2.10.2 Sandoz Major Business
    • 2.10.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Product and Solutions
    • 2.10.4 Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Sandoz Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Quetiapine Fumarate Sustained Release Tablets Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Quetiapine Fumarate Sustained Release Tablets by Company Revenue
    • 3.2.2 Top 3 Quetiapine Fumarate Sustained Release Tablets Players Market Share in 2025
    • 3.2.3 Top 6 Quetiapine Fumarate Sustained Release Tablets Players Market Share in 2025
  • 3.3 Quetiapine Fumarate Sustained Release Tablets Market: Overall Company Footprint Analysis
    • 3.3.1 Quetiapine Fumarate Sustained Release Tablets Market: Region Footprint
    • 3.3.2 Quetiapine Fumarate Sustained Release Tablets Market: Company Product Type Footprint
    • 3.3.3 Quetiapine Fumarate Sustained Release Tablets Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Quetiapine Fumarate Sustained Release Tablets Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Quetiapine Fumarate Sustained Release Tablets Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Quetiapine Fumarate Sustained Release Tablets Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Quetiapine Fumarate Sustained Release Tablets Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Quetiapine Fumarate Sustained Release Tablets Consumption Value by Type (2021-2032)
  • 6.2 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2032)
  • 6.3 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country
    • 6.3.1 North America Quetiapine Fumarate Sustained Release Tablets Consumption Value by Country (2021-2032)
    • 6.3.2 United States Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Quetiapine Fumarate Sustained Release Tablets Consumption Value by Type (2021-2032)
  • 7.2 Europe Quetiapine Fumarate Sustained Release Tablets Consumption Value by Application (2021-2032)
  • 7.3 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country
    • 7.3.1 Europe Quetiapine Fumarate Sustained Release Tablets Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 7.3.3 France Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region
    • 8.3.1 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Consumption Value by Region (2021-2032)
    • 8.3.2 China Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 8.3.5 India Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Quetiapine Fumarate Sustained Release Tablets Consumption Value by Type (2021-2032)
  • 9.2 South America Quetiapine Fumarate Sustained Release Tablets Consumption Value by Application (2021-2032)
  • 9.3 South America Quetiapine Fumarate Sustained Release Tablets Market Size by Country
    • 9.3.1 South America Quetiapine Fumarate Sustained Release Tablets Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country
    • 10.3.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Quetiapine Fumarate Sustained Release Tablets Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Quetiapine Fumarate Sustained Release Tablets Market Drivers
  • 11.2 Quetiapine Fumarate Sustained Release Tablets Market Restraints
  • 11.3 Quetiapine Fumarate Sustained Release Tablets Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Quetiapine Fumarate Sustained Release Tablets Industry Chain
  • 12.2 Quetiapine Fumarate Sustained Release Tablets Upstream Analysis
  • 12.3 Quetiapine Fumarate Sustained Release Tablets Midstream Analysis
  • 12.4 Quetiapine Fumarate Sustained Release Tablets Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Quetiapine Fumarate Sustained Release Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Quetiapine Fumarate Sustained Release Tablets market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Quetiapine Fumarate Sustained Release Tablets market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Quetiapine Fumarate Sustained Release Tablets market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Quetiapine Fumarate Sustained Release Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Quetiapine Fumarate Sustained Release Tablets market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Quetiapine Fumarate Sustained Release Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Quetiapine Fumarate Sustained Release Tablets market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Lupin Limited, Sandoz, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Quetiapine Fumarate Sustained Release Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    50mg
    200mg
    300mg
    400mg
    Market segment by Application
    Hospital
    Clinic
    Others
    Market segment by players, this report covers
    Luye Pharma Limited
    PHARMATHEN INVESTMENTS GROUP LIMITED
    Seroquel
    Teva Pharmaceutical Industries
    Dr. Reddy's Laboratories
    Sun Pharmaceutical Industries
    Mylan N.V.
    Torrent Pharmaceuticals
    Lupin Limited
    Sandoz
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Quetiapine Fumarate Sustained Release Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Quetiapine Fumarate Sustained Release Tablets, with revenue, gross margin, and global market share of Quetiapine Fumarate Sustained Release Tablets from 2021 to 2026.
    Chapter 3, the Quetiapine Fumarate Sustained Release Tablets competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Quetiapine Fumarate Sustained Release Tablets market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Quetiapine Fumarate Sustained Release Tablets.
    Chapter 13, to describe Quetiapine Fumarate Sustained Release Tablets research findings and conclusion.

    Buy now